News & Publications
Hollingsworth LLP is one of the country's leading litigation firms. Read our publications, case news, and commentary, and gain insight from attorneys at the forefront of the latest developments in complex litigation defense.
See photos and the full story.
In re: Lipitor (Atorvastatin Calcium) Marketing, Sales Practices and Prods. Liab. Litig., No. 17-1140 (4th Cir. June 12, 2018).
Meet our impressive and accomplished lawyers-to-be.
Ms. O'Brian's practice focuses on legislative work, regulatory matters, and mass tort, products liability, and class action litigation.
The court found that even were it assumed recoupment could be sanctioned under Georgia law, insurer’s reservation of rights letters were insufficient to give rise to recoupment by insured railroad.
Hollingsworth LLP represents Monsanto in In Re:Roundup Products Liability Litigation in the Northern District of California.
Firm partner Eric Lasker represented DynCorp at jury trial in U.S. District Court for the District of Columbia.
These AV® Preeminent™ rated attorneys named in October 2016 as legal industry leaders.
Hollingsworth LLP and the U.S. Chamber of Commerce filed a business coaltion amici curiae brief in support of the mobile phone makers.
Washington, DC—September 21, 2016
Norfolk Southern is represented in this matter by Firm partner Donald R. McMinn.
Neil S. Bromberg represents Novartis in U.S. District Court for the Southern District of New York.
Martin C. Calhoun for DRI's In-House Defense Quarterly
Martin C. Calhoun for Washington Legal Foundation's Legal Opinion Letter
Martin C. Calhoun and Julia M. Collison for DRI's In-House Defense Quarterly
— Gregory S. Chernack for Washington Legal Foundation's Legal Opinion Letter
For Washington Legal Foundation's Legal Backgrounder, January 2016
By Firm partner James Sullivan (For The Defense, November 2015)
For the Washington Legal Foundation Legal Pulse blog.
And see Professor Bernstein's OpEd in The Washington Post.
For The Legal Pulse, a Washington Legal Foundation blog.
Testing, Regulation and Science Concerning Perfluorooctanoic Acid and Implications for Future Litigation; Defense Counsel Journal (2009)
Bloomberg BNA Class Action Litigation Report